MARKET

APDN

APDN

Applied DNA Sciences Inc
NASDAQ

Real-time Quotes | Nasdaq Last Sale

7.84
+0.07
+0.90%
Closed 19:53 09/24 EDT
OPEN
7.66
PREV CLOSE
7.77
HIGH
7.88
LOW
7.65
VOLUME
165.99K
TURNOVER
--
52 WEEK HIGH
19.69
52 WEEK LOW
2.520
MARKET CAP
40.32M
P/E (TTM)
-1.9288
1D
5D
1M
3M
1Y
5Y
News
Financial
Releases
Corp Actions
Analysis
Profile
Applied DNA Sciences +2% PM on new supply deal for its CertainT platform
Applied DNA Sciences (APDN) enters into supply agreement with ITW Pillar Technologies to deploy its CertainT platform used to tag products with a unique molecular identifier.Under the agreement, Applied DNA will
Seekingalpha · 3d ago
Applied DNA Enters Into Supply Agreement With ITW Pillar Technologies To Bring CertainT Platform To Textiles Including Those Used In Personal Protective Equipment
Applied DNA Enters into Supply Agreement with ITW Pillar Technologies to Bring CertainT® Platform to Textiles Including Those Used in Personal Protective Equipment - CertainT to Be Deployed to Ensure Material and
Benzinga · 3d ago
Applied DNA Enters into Supply Agreement with ITW Pillar Technologies to Bring CertainT® Platform to Textiles Including Those Used in Personal Protective Equipment
Applied DNA Sciences, Inc. (NASDAQ: APDN) ("Applied DNA" or the "Company"), a leader in Polymerase Chain Reaction (PCR)-based DNA manufacturing that enables in vitro diagnostics, pre-clinical nucleic acid-based therapeutic drug candidates, supply chain security, anti-counterfeiting
Business Wire · 3d ago
Applied DNA and Takis Biotech/Evvivax to Launch Clinical Trial for Veterinary Use of Linear COVID-19 Vaccine Candidate
Applied DNA Sciences, Inc. (NASDAQ: APDN) ("Applied DNA" or the "Company"), a leader in Polymerase Chain Reaction (PCR)-based DNA manufacturing that enables in vitro diagnostics, preclinical nucleic acid-based therapeutic drug candidates, supply chain security, anti-counterfeiting
Business Wire · 09/16 09:00
Applied DNA to Present at H.C. Wainwright 22nd Annual Global Investment Conference on September 15
Applied DNA Sciences, Inc. (NASDAQ: APDN) ("Applied DNA" or the "Company"), a leader in Polymerase Chain Reaction (PCR)-based DNA manufacturing that enables in vitro diagnostics, pre-clinical nucleic acid-based therapeutic drug candidates, supply chain security, anti-counterfeiting
Business Wire · 09/02 12:00
Applied DNA Provides Update on Status of New York State Laboratory Permit for Clinical Labs Subsidiary
Applied DNA Sciences, Inc. (NASDAQ: APDN) ("Applied DNA" or the "Company"), announced that the Company’s wholly owned diagnostics testing subsidiary, Applied DNA Clinical Labs, LLC ("ADCL"), has completed all compliance and clinical data submissions required under the Clinical
Business Wire · 08/27 17:38
Is Applied DNA Sciences (NASDAQ:APDN) Using Too Much Debt?
Simply Wall St. · 08/17 11:38
Applied DNA Positions LinearDNA Platform as the Next Generation Manufacturing Platform for Adeno-Associated Virus-based Gene Therapies Through New Patent Filing
Business Wire · 08/17 11:00
More
Forecast
EPSBVPSCFPS
Actual (USD)
Estimate (USD)
Income StatementMore
Net IncomeTotal RevenueOperating Income
Net Income (USD)
YoY (%)
Balance SheetMore
Total Assets (USD)
Total Liabilities (USD)
Debt to Asset (%)
Cash FlowMore
OperatingInvestingFinancing
Operating (USD)
YoY (%)
Learn about the latest financial forecast of APDN. Analyze the recent business situations of Applied DNA Sciences Inc through EPS, BVPS, FPS, and other data. This information may help you make smarter investment decisions.
Analyst Rating

Based on 2 analysts

Buy

Disclaimer: The analysis information is for reference only and does not constitute an investment recommendation.

Analyst Price Target
The average APDN stock price target is 21.50 with a high estimate of 22.00 and a low estimate of 21.00.
EPS
Institutional Holdings
Institutions: 47
Institutional Holdings: 1.04M
% Owned: 20.21%
Shares Outstanding: 5.14M
TypeInstitutionsShares
Increased
7
57.23K
New
16
-55.14K
Decreased
1
22.43K
Sold Out
0
0
  • Performance
  • Asset Allocation
  • Dividend History
No Data
Industry
Specialty Chemicals
-0.20%
Chemicals
+0.50%
Key Executives
Chairman/President/Chief Executive Officer/Director
James Hayward
Chief Financial Officer
Beth Jantzen
Chief Information Officer
Judith Murrah
Secretary
Ming-Hwa Liang
Director
Robert Catell
Director
Elizabeth Ferguson
Independent Director
Scott Anchin
Independent Director
John Bitzer
Independent Director
Joseph Ceccoli
Independent Director
Yacov Shamash
Independent Director
Sanford Simon
  • Dividends
  • Splits
  • Insider Activity
No Data
Access Level 2 Advance
Nasdaq TotalView
for Free
Get Now
About APDN
Applied DNA Sciences, Inc. is engaged in creating security solutions addressing the challenges of modern commerce. The Company is also engaged in the large-scale production of specific deoxyribonucleic acid (DNA) sequences using the polymerase chain reaction (PCR). Its principal technology platform includes SigNature DNA, SigNature T DNA, fiberTyping, DNAnet, digitalDNA, SigNify and Beacon. Its SigNify IF portable DNA reader provides definitive real-time authentication of SigNature DNA in the field-DNA becomes a solution for supply chain integrity. SigNature DNA is the Company's platform ingredient, at the core of all its security solutions. It provides forensic power and protection for a range of applications. SigNature T DNA is a tagging and authentication system specifically designed for textiles and apparel. DNAnet is a DNA marker that can be used to definitively link evidence and offenders to specific crime scenes and help return stolen or lost property to its rightful owner.
More
Hot Stocks
Symbol
Price
%Change

Webull offers kinds of Applied DNA Sciences Inc stock information, including NASDAQ:APDN real-time market quotes, financial reports, professional analyst ratings, in-depth charts, corporate actions, APDN stock news, and many more online research tools to help you make informed decisions.

You can practice and explore trading APDN stock methods without spending real money on the virtual paper trading platform.